infect
still
much
need
clinic
econom
point
view
antivir
substanc
obtain
medicin
plant
potenti
good
target
studi
glycyrrhiza
uralensi
g
glabra
commonli
use
tradit
modern
medicin
studi
extract
g
uralensi
root
compon
examin
antihcv
activ
use
hcv
cell
cultur
system
found
methanol
extract
g
uralensi
root
chloroform
fraction
possess
antihcv
activ
inhibitori
concentr
ic
mgml
respect
bioactivityguid
purif
structur
analysi
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isol
identifi
antihcv
compound
ic
mgml
respect
howev
glycyrrhizin
major
constitu
g
uralensi
monoammonium
salt
show
margin
antihcv
activ
also
found
licochalcon
glabridin
known
exclus
constitu
g
inflata
g
glabra
respect
antihcv
activ
ic
mgml
respect
anoth
chalcon
isoliquiritigenin
also
show
antihcv
activ
ic
mgml
timeofaddit
analysi
reveal
glycyrrhizaderiv
antihcv
compound
test
studi
act
postentri
step
conclus
present
result
suggest
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isol
g
uralensi
well
isoliquiritigenin
licochalcon
glabridin
would
good
candid
seed
compound
develop
antivir
hcv
viral
genom
howev
nonstructur
protein
constitut
viral
replic
complex
replic
viral
genom
take
place
hcv
protein
also
play
essenti
role
patholog
process
associ
hcv
infect
carcinogenesi
glucos
lipid
metabol
disord
hepat
c
viru
among
major
caus
agent
chronic
hepat
hepat
cirrhosi
hepatocellular
carcinoma
global
preval
hcv
thu
million
peopl
chronic
infect
viru
worldwid
varieti
standard
treatment
regimen
use
combin
pegyl
interferon
ribavirin
directact
agent
hcvspecif
inhibitor
proteas
adopt
consider
success
howev
clinic
import
issu
remain
unsolv
emerg
drugresist
viru
cost
drug
therefor
develop
complementari
andor
altern
drug
especi
medicin
plant
treat
hcv
infect
still
much
need
clinic
econom
point
view
glycyrrhiza
uralensi
g
glabra
wide
use
supplementari
treatment
tradit
herbal
medicin
modern
medicin
radix
glycyrrhiza
spp
commonli
known
gan
cao
chines
licoric
english
bioactiv
constitu
glycyrrhiza
speci
classifi
triterpenoid
glycyrrhiz
acid
coumarin
glycycoumarin
glycyrin
glycyrol
flavon
liquiritin
liquiritigenin
chalcon
isoliquiritigenin
licochalcon
isoflavan
glabridin
stilbenoid
miscellan
compound
glycyrrhiz
acid
also
known
glycyrrhizin
consid
princip
compon
glycyrrhiza
spp
glycosyl
triterpenoid
saponin
consist
one
molecul
glycyrrhetin
acid
two
molecul
dglucuron
acid
upon
hydrolysi
aglycon
acid
simpli
call
glycyrrhetin
acid
two
molecul
dglucuron
acid
releas
glycyrrhizin
compound
isol
glycyrrhiza
speci
reportedli
antivir
activ
varieti
virus
includ
hiv
herp
simplex
viru
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
hepat
virus
enterovirus
hepat
virus
glycyrrhizin
use
treat
liver
diseas
includ
chronic
hepat
b
c
although
glycyrrhizin
decreas
serum
alanin
aminotransferas
concentr
hcvinfect
patient
significantli
reduc
amount
hcv
rna
report
glycyrrhizincontain
prepar
reduc
hepat
steatosi
transgen
mice
express
fulllength
hcv
polyprotein
recent
antihcv
activ
glycyrrhizin
vitro
report
howev
clear
evid
still
appear
lack
studi
use
hcv
cell
cultur
system
examin
methanol
extract
chloroform
subfract
g
uralensi
certain
isol
compound
well
commerci
avail
purifi
compound
glycyrrhizin
glycyrrhetin
acid
antihcv
activ
report
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isol
g
uralensi
show
antihcv
activ
wherea
glycyrrhizin
show
margin
antihcv
activ
also
found
constitu
g
uralensi
g
inflata
g
glabra
isoliquiritigenin
licochalcon
glabridin
show
antihcv
activ
cell
plasmid
kindli
provid
dr
c
rice
rockefel
univers
new
york
ny
usa
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fb
biowest
franc
nonessenti
amino
acid
invitrogen
carlsbad
ca
usa
penicillin
iuml
streptomycin
mg
ml
invitrogen
co
incub
cell
cultureadapt
strain
hcv
genotyp
prepar
describ
previous
use
studi
moi
extract
subfraction
purif
g
uralensi
root
g
uralensi
root
purchas
tochimoto
tenkaido
osaka
japan
methanol
extract
g
uralensi
root
prepar
subject
purif
procedur
describ
previous
brief
g
uralensi
root
dri
room
temperatur
pulver
extract
methanol
hr
extract
filter
filtrat
concentr
use
evapor
temperatur
exceed
residu
obtain
resuspend
water
success
partit
chloroform
nbutanol
chloroform
extract
subject
recycl
prepar
hplc
solvent
system
methanol
column
mm
id
mm
flow
rate
mlmin
detect
uv
nm
condit
afford
fraction
subject
hplc
separ
solvent
system
acetonitrilewat
column
imtakt
unison
kyoto
japan
mm
id
mm
flow
rate
mlmin
detect
uv
nm
give
fraction
glycyrin
mg
purifi
recycl
hplc
condit
afford
glycycoumarin
mg
combin
rechromatograph
hplc
solvent
system
acetonitrilewat
column
imtakt
unison
mm
id
mm
flow
rate
mlmin
detect
uv
nm
give
fraction
fr
subject
recycl
hplc
condit
give
liquiritigenin
mg
purifi
recycl
hplc
condit
afford
glycyrol
mg
hand
cnmr
spectra
measur
jeol
eca
spectromet
mhz
tokyo
japan
hplc
perform
plu
system
tokyo
japan
glycyrrhiz
acid
cat
glycyrrhiz
acid
monoammonium
salt
nhydrat
cat
glycyrrhetin
acid
cat
glabridin
cat
purchas
wako
pure
chemic
industri
osaka
japan
liquiritin
cat
liquiritigenin
cat
licochalcon
cat
purchas
sigmaaldrich
tokyo
japan
isoliquiritigenin
cat
tokyo
chemic
industri
tokyo
japan
licoricesaponin
cat
cat
glycyrrhet
acid
cat
purchas
funakoshi
tokyo
japan
glycycoumarin
glycyrol
glycyrin
liquiritigenin
isol
g
uralensi
extract
studi
describ
test
sampl
weigh
dissolv
dmso
obtain
stock
solut
mgml
stock
solut
store
use
cell
seed
plate
cellswel
hcv
mix
serial
dilut
test
sampl
mgml
inocul
cell
hr
cell
wash
medium
remov
residu
viru
incub
medium
contain
concentr
sampl
viru
inocul
timeofaddit
experi
treatment
sampl
perform
viru
inocul
order
assess
mode
action
sampl
examin
cultur
supernat
collect
day
postinfect
titrat
viru
infect
describ
viru
cell
treat
medium
contain
dmso
serv
control
percent
inhibit
viru
infect
dilut
sampl
calcul
comparison
mocktreat
control
ic
determin
viru
sampl
dilut
serial
complet
medium
inocul
onto
cell
seed
glass
coverslip
plate
viru
adsorpt
hr
cell
wash
medium
remov
residu
viru
cultur
hr
virusinfect
cell
stain
indirect
immunofluoresc
method
report
previous
brief
virusinfect
cell
wash
pb
fix
paraformaldehyd
min
permeabil
triton
pb
min
room
temperatur
wash
three
time
pb
cell
incub
hcvinfect
patient
serum
hr
follow
incub
fitcconjug
goat
antihuman
igg
mbl
nagoya
japan
cell
counterstain
hoechst
molecular
probe
eugen
usa
min
hcvinfect
cell
count
fluoresc
microscop
keyenc
osaka
japan
cytotox
sampl
assess
assay
describ
previous
slight
modif
brief
cell
plate
treat
serial
dilut
sampl
dmso
control
hr
end
treatment
ml
reagent
roch
mannheim
germani
ad
well
cell
cultur
hr
reagent
absorb
cell
convert
formazan
mitochondri
dehydrogenas
amount
formazan
correl
number
live
cell
determin
measur
absorb
well
use
micropl
reader
nm
percent
cell
viabil
compar
control
calcul
dilut
sampl
cc
determin
cell
lyse
sd
sampl
buffer
equal
amount
protein
subject
sdspolyacrylamid
gel
electrophoresi
transfer
onto
polyvinyliden
difluorid
membran
millipor
bedford
usa
describ
previous
membran
incub
respect
primari
antibodi
primari
antibodi
use
mous
monoclon
antibodi
hcv
gapdh
millipor
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
invitrogen
use
visual
respect
protein
mean
enhanc
chemiluminesc
detect
system
ecl
ge
healthcar
buckinghamshir
uk
realtim
quantit
rtpcr
perform
describ
previous
brief
total
rna
extract
cell
use
reliaprep
rna
cell
miniprep
system
promega
madison
wi
usa
accord
manufactur
instruct
one
microgram
total
rna
revers
transcrib
use
goscript
revers
transcript
system
promega
random
primer
subject
realtim
quantit
pcr
analysi
use
sybr
premix
ex
taq
takara
kyoto
japan
microamp
reaction
plate
abi
prism
system
appli
biosystem
foster
citi
ca
usa
hcvspecif
primer
amplifi
region
viral
genom
sens
antisens
human
gapdh
gene
express
measur
use
primer
sens
serv
intern
control
antihcv
activ
methanol
extract
subfract
g
uralensi
root
first
examin
crude
methanol
extract
g
uralensi
root
antihcv
activ
use
hcv
strain
cell
ic
cc
valu
crude
methanol
extract
mgml
respect
select
index
si
cc
ic
tabl
partit
methanol
extract
use
differ
solvent
found
antihcv
activ
concentr
chloroform
partit
whose
ic
cc
mgml
respect
si
next
subfraction
chloroform
partit
use
recycl
hplc
examin
subfract
antihcv
activ
found
signific
antihcv
activ
fraction
ic
rang
mgml
tabl
tri
purifi
major
compon
fraction
use
recycl
hplc
identifi
glycycoumarin
glycyrin
glycyrol
liquiritigenin
nmr
spectrum
analysi
data
shown
antihcv
activ
g
uralensisderiv
purifi
compound
relat
chemic
compound
obtain
glycyrrhiza
speci
examin
purifi
compound
obtain
g
uralensi
extract
glycycoumarin
glycyrin
glycyrol
liquiritigenin
glycyrrhizaderiv
chemic
compound
glycyrrhizin
deriv
found
glycyrrhizin
glycyrrhiz
acid
monoammonium
salt
glycyrrhiz
acid
monoammonium
latter
watersolubl
former
possess
margin
antihcv
activ
ic
valu
mgml
respect
tabl
aglycon
glycyrrhizin
glycyrrhetin
acid
show
signific
antihcv
activ
glycyrrhizin
ic
mgml
note
antihcv
activ
weaker
recycl
hplc
fraction
g
uralensi
extract
monoglucuronid
form
glycyrrhizin
glycyrrhet
acid
show
signific
antihcv
activ
concentr
test
result
suggest
anoth
compound
fraction
respons
antihcv
activ
two
saponin
test
studi
licoricesaponin
show
detect
antihcv
activ
hand
coumarin
glycycoumarin
glycyrin
glycyrol
isol
studi
puriti
g
uralensi
extract
show
potent
antihcv
activ
ic
mgml
liquiritigenin
also
isol
g
uralensi
extract
show
weaker
antihcv
activ
coumarin
also
isoliquiritigen
licochalcon
glabridin
exhibit
potent
antihcv
activ
ic
mgml
respect
note
licochalcon
glabridin
report
absent
g
uralensi
present
g
inflata
g
glabra
determin
whether
antihcv
effect
compound
glycyrrhiza
speci
exert
entri
postentri
stage
perform
follow
timeofaddit
experi
found
glycyrrhiza
speciesderiv
compound
well
chloroform
partit
g
uralensi
extract
exert
antivir
effect
viru
inocul
tabl
result
suggest
antihcv
compound
glycyrrhiza
speci
test
studi
name
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isoliquiritigenin
licochalcon
glabridin
well
chloroform
extract
act
primarili
postentri
step
inhibit
hcv
rna
replic
hcv
protein
synthesi
glycycoumarin
glycyrin
glycyrol
obtain
g
uralensi
confirm
g
uralensisderiv
compound
exert
antihcv
activ
postentri
step
cell
inocul
hcv
hr
follow
treatment
compound
day
result
obtain
clearli
demonstr
glycycoumarin
glycyrin
glycyrol
inhibit
hcv
rna
replic
result
decreas
hcv
protein
synthesi
demonstr
realtim
quantit
rtpcr
immunoblot
analys
fig
b
also
confirm
product
hcv
infecti
particl
inhibit
glycycoumarin
glycyrin
glycyrol
day
postinfect
fig
glycyrrhiza
speci
possess
varieti
bioactiv
compound
triterpenoid
exampl
glycyrrhizin
glycyrrhet
acid
glycyrrhetin
acid
variou
licoricesaponin
ii
coumarin
exampl
glycycoumarin
glycyrin
glycyrol
iii
flavanon
exampl
liquiritin
liquiritigenin
iv
chalcon
exampl
isoliquiritigenin
licochalcon
v
isoflavan
exampl
glabridin
vi
stilbenoid
exampl
dihydrostilben
miscellan
compound
connect
flavanon
chalcon
isoflavan
member
flavonoid
glycyrrhizin
major
constitu
glycyrrhiza
speci
repres
total
glycyrrhizin
compound
isol
glycyrrhiza
speci
reportedli
possess
antivir
activ
varieti
virus
regard
hcv
recent
report
glycyrrhizin
inhibit
hcv
infect
cell
hand
controversi
observ
report
clinic
set
name
glycyrrhizin
signific
effect
amount
hcv
rna
wherea
reduc
serum
alanin
aminotransferas
concentr
hcvinfect
patient
appar
contradictori
find
might
explain
membranestabil
effect
glycyrrhizin
clear
evid
antivir
activ
glycyrrhizin
still
lack
present
studi
observ
glycyrrhizin
glycyrrhiz
acid
monoammonium
show
margin
antihcv
activ
tabl
glycyrrhetin
acid
show
signific
antihcv
activ
howev
antihcv
activ
significantli
weaker
hplc
fraction
obtain
g
uralensi
extract
hand
found
certain
coumarin
glycycoumarin
glycyrin
glycyrol
flavanon
liquiritigenin
isol
g
uralensi
well
compound
contain
glycyrrhiza
speci
possess
potent
antihcv
activ
modeofact
analysi
reveal
glycyrrhizaderiv
antihcv
compound
test
act
primarili
postentri
step
consist
observ
research
also
report
two
flavonoid
isoliquiritigenin
glycycoumarin
extract
glycyrrhiza
radix
either
g
uralensi
g
glabra
inhibit
replic
hcv
subgenom
rna
replicon
vitro
ic
valu
isoliquiritigenin
glycycoumarin
hcv
subgenom
replicon
mgml
respect
hand
best
knowledg
publish
report
far
regard
antihcv
activ
glycyrin
glycyrol
report
glycyrin
known
possess
peroxisom
proliferatoractiv
receptorg
ligandbind
activ
show
antibacteri
activ
streptococcu
pyogen
haemophilu
influenza
moraxella
catarrhali
glycyrol
reportedli
exert
antiinflammatori
effect
bind
calcineurin
inhibit
activ
howev
possibl
antimicrobi
activ
glycyrol
report
studi
need
elucid
detail
mechan
antihcv
activ
glycyrin
glycyrol
also
possibl
antivir
activ
virus
hcv
conclus
result
suggest
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isol
g
uralensi
well
isoliquiritigenin
licochalcon
glabridin
would
good
candid
seed
compound
develop
antivir
hcv
